The following is a reconciliation of the basic and diluted loss per share computations:


	Three-Months Ended						Six-Months Ended
	June 30, 2026			June 30, 2025			June 30, 2026			June 30, 2025
(in thousands, except share and per share amounts)
Net loss	$	(7,663	)	$	(9,920	)	$	(18,274	)	$	(23,779	)
Weighted-average common shares—outstanding, basic and diluted		30,749,894			26,367,548			30,645,960			26,400,366
Net loss per common share, basic and diluted	$	(0.25	)	$	(0.38	)	$	(0.60	)	$	(0.90	)


	Three-Months Ended				Six-Months Ended
	June 30, 2026		June 30, 2025		June 30, 2026		June 30, 2025
Anti-dilutive shares excluded from diluted net loss per common share:
Stock options		5,088,345		5,149,976		5,088,345		5,149,976
Restricted stock units		935,378		99,504		935,378		99,504
ESPP		131,680		58,959		131,680		58,959
Warrants		909,661		554,841		909,661		554,841

The Company’s basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of Common Stock outstanding for the relevant period. In accordance with ASC 710, shares of Common Stock held by the rabbi trust are excluded from the denominator in both the basic and the diluted net loss per common share calculations. As of June 30, 2026 and 2025, a total of 75,391 and 125,276 shares of Common Stock were excluded, respectively. For the purposes of the calculation of diluted net loss per share, options to purchase Common Stock, restricted stock units, and unvested shares of Common Stock issued upon the early exercise of stock options have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive. Because the Company has reported a net loss for the three- and six-months ended June 30, 2026 and 2025, diluted net loss per common share is the same as the basic net loss per share for those periods.